Experience

Lexitas Pharma Services

• United States
• Research Services
• 100 - 200 Employee

• Therapeutic Strategy Director

  • Oct 2023 - Present

  Raleigh-Durham-Chapel Hill Area



Apellis Pharmaceuticals

• United States
• Biotechnology Research
• 500 - 600 Employee

• Director, Global Marketing - Ophthalmology

  • Apr 2023 - Oct 2023

  United States Director for SYFOVRE’s global brand strategy, key messaging, competitive strategy, and global HCP campaign in collaboration with 3M stakeholders (marketing, medical, market access). Led a cross functional team to scenario plan and strengthen our global core narrative for SYFOVRE in preparation for competitor launch and multiple anticipated global launches for SYFOVRE in 2024. Commercial lead on pre-filled syringe core team including TPP alignment, KOL engagement for insights, & key design… Show more Director for SYFOVRE’s global brand strategy, key messaging, competitive strategy, and global HCP campaign in collaboration with 3M stakeholders (marketing, medical, market access). Led a cross functional team to scenario plan and strengthen our global core narrative for SYFOVRE in preparation for competitor launch and multiple anticipated global launches for SYFOVRE in 2024. Commercial lead on pre-filled syringe core team including TPP alignment, KOL engagement for insights, & key design considerations. Partnered with 5 global patient advocacy groups to lay the foundation for World Geographic Atrophy Day. Content creation, PRC review, and facilitation of global commercial advisory boards – live & virtual. Led global commercial tactical planning workshop for 2024. Creative agency performance oversight and budget planning

• Senior Director, Thought Leader Liaisons - Ophthalmology

  • Apr 2022 - Apr 2023

  Raleigh, North Carolina, United States Led Apellis Ophthalmology TLL team to identify and gather valuable insights from retina KOLs to help inform our commercial strategy for the U.S. launch of SYFOVRE. Exceeded company launch forecast for SYFOVRE, delivering 60,000+ vials in the first two quarters of 2023. Hired industry leading TLL team in just 6 weeks – 6 individuals spanning the country with extensive retina experience (75+ years collectively) and prior retina launch experience across 9 different companies. Established… Show more Led Apellis Ophthalmology TLL team to identify and gather valuable insights from retina KOLs to help inform our commercial strategy for the U.S. launch of SYFOVRE. Exceeded company launch forecast for SYFOVRE, delivering 60,000+ vials in the first two quarters of 2023. Hired industry leading TLL team in just 6 weeks – 6 individuals spanning the country with extensive retina experience (75+ years collectively) and prior retina launch experience across 9 different companies. Established commercial KOL target list of ~300 established and emerging retina thought leaders. Reached 93% of targets within 2 weeks of launch to gather insights & begin driving advocacy for SYFOVRE. Facilitated KOL panel from stage at SYFOVRE launch meeting in February 2023. Identified and helped train 50+ KOL speakers for DSE and branded speaker programs; 63 DSE programs completed in just 3 months prior to SYFOVRE launch. Established TLL insights gathering process to regularly share strategic insights with BI & Marketing. TLL team attended 20+ congresses in year 1 and played a key role connecting KOLs with Apellis commercial leadership, cross functional partners, and establishing a strong KOL network with the company prior to launch



Dompé

• Italy
• Pharmaceutical Manufacturing
• 500 - 600 Employee

• Senior Director, Ophthalmology Strategy & Interim Lead Pipeline Strategy

  • Nov 2021 - Apr 2022

  Raleigh, North Carolina, United States Lead the Ophthalmology Strategy team for Dompe U.S. Key responsibilities include managing the Oxervate forecast (short and long term), delivering monthly business reviews, leverage and generate business and analytical insights to help inform strategic direction of the Oxervate brand (i.e. competitive intelligence, payer & customer behavior analytics), assess the evolving NK marketplace for growth drivers, lead ATU development and execution, KPI tracking, generate target lists for the… Show more Lead the Ophthalmology Strategy team for Dompe U.S. Key responsibilities include managing the Oxervate forecast (short and long term), delivering monthly business reviews, leverage and generate business and analytical insights to help inform strategic direction of the Oxervate brand (i.e. competitive intelligence, payer & customer behavior analytics), assess the evolving NK marketplace for growth drivers, lead ATU development and execution, KPI tracking, generate target lists for the commercial field team, partner with brand marketing to assess tactic effectiveness, and spearhead our data generation and go-to-market strategy for future ophthalmic indications. Also continued to oversee our commercial strategy and pipeline planning for Dompe's non-ophthalmology pipeline products - specifically Ladarixin & Reparixin.

• Senior Director, Commercial Planning - Pipeline Products

  • Jun 2021 - Nov 2021

  Raleigh, North Carolina, United States U.S. and global commercial planning for Dompe's non-ophthalmology pipeline products with a focus on Ladarixin and Reparixin to maximize the overall value of these programs for patients and for Dompe. Collaboration with medical, regulatory, and global product team to identify opportunities, develop our indication strategy, data generation plans, market & payer research, commercial strategy, and internal timelines & cross functional communication.

• Senior Director, Field Marketing & Commercial Training

  • Jun 2019 - Jun 2021

  Raleigh, North Carolina Built and led the U.S. Field Marketing function for Dompe - responsible for developing and executing the company's annual commercial congress strategy, KOL strategy, peer to peer education (including speaker bureau and educational symposia), and commercial & leadership training. Thoughtfully scaled the team from 1 employee to 9 in 18-months based on multiple examples of impact to the organization. Most recently managed a team of 3 including two Directors, each with direct reports.… Show more Built and led the U.S. Field Marketing function for Dompe - responsible for developing and executing the company's annual commercial congress strategy, KOL strategy, peer to peer education (including speaker bureau and educational symposia), and commercial & leadership training. Thoughtfully scaled the team from 1 employee to 9 in 18-months based on multiple examples of impact to the organization. Most recently managed a team of 3 including two Directors, each with direct reports. Responsible for overall strategy, tactical planning, budget management, and vendor management / contracting for our team, including oversight of ~$2.5M annual budget and 5 large vendors & SOWs. Team focus on engaging the right KOLs and channels to build advocacy for our company and our product, differentiating Dompe through unique and memorable experiences, and strategic partnerships at the region level to unlock new opportunities for growth. Collaborate on brand messaging and tactics, commercial ad board content and advisor recommendations, coach & train all commercial speakers, ensure operational excellence for peer to peer education programs, and have played a key role in shaping our overall strategy with cornea specialists and most recently the optometric community. Successfully launched the Oxervate speaker’s bureau including development of all business rules and two content platforms for strategic targeting of HCPs. Currently working with over 40 of the most highly respected Cornea Specialists and Optometrists in the industry as educators on neurotropic keratitis and Oxervate. In the first 8 months of our bureau, completed over 50 programs with 600+ attendees, 75% of which were physicians and several new prescribers of Oxervate. Despite challenges posed by Covid-19, we quickly converted our platform to virtual in less than 2 weeks and completed more programs in 1H'2020 than the prior year combined.

• Director, East Region

  • Sep 2018 - Jun 2019

  Raleigh, North Carolina Joined as the 4th employee of Dompe U.S. to help build the company and launch Oxervate in the U.S. market in just 4 months. Oxervate is the first FDA approved therapy for neurotropic keratitis, a rare disease affecting corneal nerves, and the first topical biologic approved in ophthalmology. Dompe U.S. grew from 4 employees to 70 in just 16 months, and achieved nearly 7x our revenue target in year 1 of launch. Hired and led initial East Region sales team of 9 KAMs to launch Oxervate -… Show more Joined as the 4th employee of Dompe U.S. to help build the company and launch Oxervate in the U.S. market in just 4 months. Oxervate is the first FDA approved therapy for neurotropic keratitis, a rare disease affecting corneal nerves, and the first topical biologic approved in ophthalmology. Dompe U.S. grew from 4 employees to 70 in just 16 months, and achieved nearly 7x our revenue target in year 1 of launch. Hired and led initial East Region sales team of 9 KAMs to launch Oxervate - built the sales team infrastructure and territory maps, IC plans, field coaching reports, new hire training, and planned a successful launch meeting. Collaborated with Marketing to create launch areas of focus and core messaging for Oxervate, brand positioning, and assess claims and ATU market research data to shape overall strategy and sales targets at launch.



Genentech

• United States
• Biotechnology Research
• 700 & Above Employee

• Division Manager, Genentech BioOncology

  • Sep 2015 - Sep 2018

  Raleigh, NC Built and led a new team to achieve "Division of the Year" in just 12 months and achieved some of the highest team engagement scores in the franchise. Despite being new to Oncology and a new addition among seasoned managers, won the Peer Leadership Award during first year in BioOncology. Managed a team of 7 Clinical Specialists, responsible for Avastin sales in metastatic colorectal, ovarian, and cervical cancer. Successfully hired and onboarded 5 new Clinical Specialists to the organization… Show more Built and led a new team to achieve "Division of the Year" in just 12 months and achieved some of the highest team engagement scores in the franchise. Despite being new to Oncology and a new addition among seasoned managers, won the Peer Leadership Award during first year in BioOncology. Managed a team of 7 Clinical Specialists, responsible for Avastin sales in metastatic colorectal, ovarian, and cervical cancer. Successfully hired and onboarded 5 new Clinical Specialists to the organization in 2015 & 2016. Successfully grew and maintained Avastin's market share in approved GI & GYN indications and in an increasingly competitive marketplace through a focus on clinical excellence, selling skills, and driving team engagement.

• Region Program Manager, LUCENTIS East Region

  • Jan 2014 - Aug 2015

  Raleigh, NC Hired as the first East Region RPM for the LUCENTIS franchise. Developed new data tools and training to enhance targeting, account planning, resource utilization, and drive sales for the East region. Conducted several field rides including verbal and written feedback to sharpen selling and business planning skills with the sales team.

• Sr. Product Manager, LUCENTIS Marketing - Access & Distribution

  • Nov 2012 - Dec 2013

  South San Francisco, CA Led overall program operations and vendor management for LUCENTIS Direct and LUCENTIS Co-Pay Card, key programs assisting with patient out of pocket cost and national distribution of our product. Also responsible for development of all promotional materials and website content for these programs. Led ongoing enhancements to the LUCENTIS Co-Pay card usability and customer experience, resulting in significant growth for the program - 6100 patient enrollments in 2013 (vs. goal of 5500 and… Show more Led overall program operations and vendor management for LUCENTIS Direct and LUCENTIS Co-Pay Card, key programs assisting with patient out of pocket cost and national distribution of our product. Also responsible for development of all promotional materials and website content for these programs. Led ongoing enhancements to the LUCENTIS Co-Pay card usability and customer experience, resulting in significant growth for the program - 6100 patient enrollments in 2013 (vs. goal of 5500 and 1600 enrollments the prior year). Formed and led LUCENTIS Direct core team, including members from brand, customer operations, finance, eMarketing, and 3 external vendors. LUCENTIS Direct sales accounted for 85% of total LUCENTIS volume during this time.

• Sales Trainer, LUCENTIS

  • Jul 2011 - Nov 2012

  South San Francisco, CA Developed sales training for our existing Clinical Specialist team and led Foundation and Core training for our new hires. Extensive collaboration with the sales leadership team, marketing, and field sales to identify training needs for the brand, and develop innovative and effective training initiatives to meet these needs. Led franchise sales training in 2012 for the launch of LUCENTIS in DME (Diabetic Macular Edema), including creation of DME training modules and eLearnings… Show more Developed sales training for our existing Clinical Specialist team and led Foundation and Core training for our new hires. Extensive collaboration with the sales leadership team, marketing, and field sales to identify training needs for the brand, and develop innovative and effective training initiatives to meet these needs. Led franchise sales training in 2012 for the launch of LUCENTIS in DME (Diabetic Macular Edema), including creation of DME training modules and eLearnings, development of "DME Eyedol" - an interactive training tool to enhance field engagement and knowledge retention, and execution of 4 live training workshops for the brand at the DME launch meeting.

• Clinical Specialist - LUCENTIS

  • Feb 2006 - Aug 2011

  Charlotte, NC Successfully launched LUCENTIS into the market in 2006 as a treatment for wet age-related macular degeneration, and also in 2009 for retinal vein occlusion. In addition to clinical knowledge, developed deep expertise in retina practice economics, buy & bill process, and market access programs.

• Field to Home Office Intern - LUCENTIS CT&D

  • Aug 2010 - Nov 2010

  South San Francisco, CA Enhanced 6-week LUCENTIS Foundation Training curriculum by creating an interactive, web-based roadmap to guide the learner through their 6-week training plan using a variety of media and learning platforms



Vistakon, Johnson & Johnson Vision Care, Inc

• Field Sales Trainer, Senior Sales Representative

  • 2002 - 2006

  Jacksonville, FL & Birmingham, AL